393 related articles for article (PubMed ID: 1171141)
1. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.
Peter HH; Knoop F; Kalden JR
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):263-81. PubMed ID: 134545
[TBL] [Abstract][Full Text] [Related]
3. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
[TBL] [Abstract][Full Text] [Related]
4. Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells.
Brier AM; Chess L; Schlossman SF
J Clin Invest; 1975 Dec; 56(6):1580-6. PubMed ID: 53242
[TBL] [Abstract][Full Text] [Related]
5. Human peripheral Nullymphocytes: ultrastructural aspects of the "K" cell effect against a melanoma target cell.
Cesarini JP; Roubin R; Kalden JR; Peter HH
Biomedicine; 1978; 28(4):219-25. PubMed ID: 737273
[TBL] [Abstract][Full Text] [Related]
6. Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals.
Fauci AS; Balow JE; Pratt KR
J Clin Invest; 1976 Apr; 57(4):826-35. PubMed ID: 947955
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated cytotoxicity. Characterization of the effector cells.
De Bracco MM; Isturiz MA; Manni JA
Immunology; 1976 Mar; 30(3):325-33. PubMed ID: 1254320
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous cytotoxicity (SCMC) of normal human lymphocytes against a human melanoma cell line: a phenomenon due to a lymphotoxin-like mediator.
Peter HH; Eife RF; Kalden JR
J Immunol; 1976 Feb; 116(2):342-8. PubMed ID: 1082453
[TBL] [Abstract][Full Text] [Related]
9. Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells.
West WH; Cannon GB; Kay HD; Bonnard GD; Herberman RB
J Immunol; 1977 Jan; 118(1):355-61. PubMed ID: 299761
[TBL] [Abstract][Full Text] [Related]
10. Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma.
Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
Cancer Res; 1975 Dec; 35(12):3721-30. PubMed ID: 1192430
[TBL] [Abstract][Full Text] [Related]
11. Correlation between effector lymphocytes in natural and antibody-mediated cytotoxicity.
Benczur M; Györffy G; Garam T; Varga M; Medgyesi G; Sándor M; Petranyi GG
Immunobiology; 1979 Sep; 156(3):320-9. PubMed ID: 540970
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
13. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
[TBL] [Abstract][Full Text] [Related]
14. Human peripheral blood "null-lymphocytes", a highly enriched pool for granulocytic stem cells (CFU-C).
Oehl S; Schaefer UW; Boecker WR; Kalden JR; Peter HH
Z Immunitatsforsch Immunobiol; 1977 Feb; 152(5):423-30. PubMed ID: 300203
[TBL] [Abstract][Full Text] [Related]
15. Identification of the cell population involved in viral-specific cell-mediated cytotoxicity in man: evidence for T cell specificity.
Rola-Pleszczynski M; Hurtado RC; Woody JN; Sell KW; Vincent MM; Hensen SA; Bellanti JA
J Immunol; 1975 Jul; 115(1):239-42. PubMed ID: 50349
[TBL] [Abstract][Full Text] [Related]
16. Human lymphocyte cytotoxicity against mumps virus-infected target cells. Requirement for non-T cells.
Härfast B; Andersson T; Perlmann P
J Immunol; 1975 Jun; 114(6):1820-3. PubMed ID: 1168673
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous cell-mediated cytotoxicity by human peripheral blood lymphocytes in vitro.
Nelson DL; Bundy BM; Strober W
J Immunol; 1977 Oct; 119(4):1401-5. PubMed ID: 894045
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
19. Human monocyte-macrophage-mediated antibody-dependent cytotoxicity to herpes simplex virus-infected cells.
Kohl S; Starr SE; oleske JM; Shore SL; Ashman RB; Nahmias AJ
J Immunol; 1977 Mar; 118(3):729-35. PubMed ID: 191525
[TBL] [Abstract][Full Text] [Related]
20. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
